Biosimilar Competition: Lessons from Europe and Prospects for the US

At this OHE Lunchtime Seminar, Professor Henry Grabowski presented the results of his recent research on competition in five European countries on Eprex® (epoetin alpha) and Neupogen® (filigrastim) and their biosimilars. He also discussed experience with two biosimilar-like products in the US and identified barriers to market penetration by biosimilars.

Friday, 14 March 2014